James increased its price target on shares of NOV Inc. (NYSE:NOV) to $19.00, up from the previous target of $18.00, while keeping an Outperform rating on the stock. Currently trading at $16.43, NOV ...

Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the following investor conferences. BTIG 12th Annual MedTech, ...

Raymond James Financial (RJF) reported impressive financial results for Q1 FY2025, exceeding analysts' expectations with an ...